Results 211 to 220 of about 13,123 (252)

The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: HIPEC Technologies

Annals of Surgical Oncology
This manuscript reports the results of an international consensus on technologies of hyperthermic intraperitoneal perioperative chemotherapy (HIPEC) performed with the following goals: To provide recommendations for the technological parameters to perform HIPEC.
Kurt, Van der Speeten, Shigeki, Kusamura, Laurent, Villeneuve, Pompiliu, Piso, Vic J, Verwaal, Santiago, González-Moreno, Olivier, Glehen   +6 more
openaire   +2 more sources

Hyperthermic Intra Peritoneal Chemotherapy (HIPEC)

International Journal of Nursing Education, 2022
Abdominal cancer in advanced stages known to be less responsive to any treatment modalities has gained positive results with HIPEC procedure done after a complete cyto-reductive surgery. HIPEC causes selective cell killing of the malignant cell, enhances the drug potency and increases the tissue penetration by the chemo therapeutic agent.
null Sonia P Abraham, null Malini Rachel C.V, null Daisy Sheeba   +2 more
openaire   +1 more source

Peritoneal carcinomatosis from colorectal cancer: HIPEC?

Surgical Oncology, 2007
Peritoneal carcinomatosis (PC) is a frequent terminal evolution from colorectal cancer. At the time of diagnosis of colon malignancies, PC affects approximately 10% of the patients [1]. Medical oncologists and gastrointestinal surgeons had considered it to be an untreatable condition for its unfavorable prognosis with a median survival of 6-9 months [1]
G, Confuorto, M E, Giuliano, A, Grimaldi, C, Viviano   +3 more
openaire   +2 more sources

Hyperthermic intraperitoneal chemotherapy (HIPEC) for gynecological cancer

Journal of Obstetrics and Gynaecology Research, 2020
AbstractAimHyperthermic intraperitoneal chemotherapy (HIPEC) is a method of administering anticancer agents directly while heating the abdominal cavity. The aim of this review is to know the current position of HIPEC in ovarian cancer and uterine sarcoma and its future prospects.MethodsThis article reviews the current literature and evidence for the ...
Hideaki, Tsuyoshi, Daisuke, Inoue, Tetsuji, Kurokawa, Yoshio, Yoshida   +3 more
openaire   +2 more sources

Anästhesiologisches Vorgehen bei HIPEC

Journal Club AINS, 2013
Zytoreduktive Chirurgie in Kombination mit hyperthermer intraperitonealer Chemotherapie (HIPEC) ist bei bestimmten Malignomen mit Beteiligung des Peritoneums ein vielversprechender Behandlungsweg. Fur den Anasthesisten ist dieses Verfahren eine multimodale Herausforderung mit dem Ziel eines optimalen perioperativen Managements. Einen Uberblick uber die
openaire   +1 more source

The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: Epithelial Ovarian Cancer

Annals of Surgical Oncology, 2023
A. Bhatt, O. Glehen, O. Zivanovic, Donal J Brennan, C. Nadeau, W. V. van Driel, Naoual Bakrin   +6 more
semanticscholar   +1 more source

Cytoreductive Surgery With or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer: A Phase 3 Clinical Trial

Annals of Surgical Oncology, 2021
Cascales Campos Pedro Antonio, González-Gil Alida, Gil Elena, González Sánchez Rocío, Martínez García Jerónimo, A. Luis, Nieto Díaz Aníbal, Barceló Valcárcel Francisco, Gómez Ruiz Álvaro Jesús, Ramírez Romero Pablo, G. José   +10 more
semanticscholar   +1 more source

Liver Resection and HIPEC

2019
Synchronous intra-parenchymal hepatic involvement (HI) in patients with peritoneal disease (PD) has traditionally served as a contraindication for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). However, several studies have demonstrated the feasibility and safety of combined liver resection with CRS/HIPEC in well ...
Laura M. Enomoto, Edward A. Levine, Perry Shen, Konstantinos I. Votanopoulos   +3 more
openaire   +1 more source

HIPEC + EPIC versus HIPEC‐alone: Differences in major complications following cytoreduction surgery for peritoneal malignancy

Journal of Surgical Oncology, 2012
AbstractIntroductionPeritoneal metastases (PM) can be treated with cytoreduction surgery (CRS) with intraoperative heated intraperitoneal chemotherapy (HIPEC) plus or minus early postoperative intraperitoneal chemotherapy (EPIC). HIPEC + EPIC may be associated with more complications than HIPEC alone.MethodsA prospective database of consecutive ...
Yarrow J, McConnell, Lloyd A, Mack, Wesley P, Francis, Thomas, Ho, Walley J, Temple   +4 more
openaire   +2 more sources

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Combined with Surgery: A 12-Year Meta-Analysis of this Promising Treatment Strategy for Advanced Gastric Cancer at Different Stages

Annals of Surgical Oncology, 2022
Jian-Feng Zhang, Ling Lv, Shuai Zhao, Qian Zhou, Cheng-gang Jiang   +4 more
semanticscholar   +1 more source